When my father started taking Aricept (a cholinesterase inhibitor) a few years ago, it cost my parents $138 per month. When his doctor added Namenda, their monthly cost for just those two medicines was well over $200.
The price of cholinesterase inhibitors may be coming down soon, at least in the U.S. This is because the Food and Drug Administration (FDA) has approved four companies’ applications to offer generic versions of Razadyne (galantamine). Based on testing for “bioequivalence,” the FDA believes that these generic versions have the same therapeutic effects as branded Razadyne does.